199 related articles for article (PubMed ID: 36038303)
1. [Clinical analysis of 7 children infected with
Xie G; Chen JH; Sun LF; Wang W; Li ZC; Wang WJ
Zhonghua Er Ke Za Zhi; 2022 Sep; 60(9):925-929. PubMed ID: 36038303
[No Abstract] [Full Text] [Related]
2. Clinical characteristics of tracheobronchial
Pan M; Fang G; Zheng F; Lin F; Zeng W; Qiu Y; Deng J; Chen X; Zhang J
Ann Med; 2023; 55(2):2276310. PubMed ID: 37967226
[TBL] [Abstract][Full Text] [Related]
3. Talaromyces marneffei infection and complicate manifestation of respiratory system in HIV-negative children.
Yang Q; Wu Y; Li X; Bao Y; Wang W; Zheng Y
BMC Pulm Med; 2023 Mar; 23(1):100. PubMed ID: 36978020
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and Prognosis of Talaromyces marneffei Infection in Non-HIV-Infected Children in Southern China.
Guo J; Li BK; Li TM; Wei FL; Fu YJ; Zheng YQ; Pan KS; Huang CY; Cao CW
Mycopathologia; 2019 Dec; 184(6):735-745. PubMed ID: 31473910
[TBL] [Abstract][Full Text] [Related]
5. Peripheral immune profile of children with Talaromyces marneffei infections: a retrospective analysis of 21 cases.
Zeng Q; Jin Y; Yin G; Yang D; Li W; Shi T; Lu G; Huang L; Fan H
BMC Infect Dis; 2021 Mar; 21(1):287. PubMed ID: 33743629
[TBL] [Abstract][Full Text] [Related]
6. Rapid diagnosis of
Liu L; Sun B; Ying W; Liu D; Wang Y; Sun J; Wang W; Yang M; Hui X; Zhou Q; Hou J; Wang X
Front Cell Infect Microbiol; 2022; 12():987692. PubMed ID: 36159645
[No Abstract] [Full Text] [Related]
7. Characteristics and Prognosis of Talaromyces marneffei Infection in HIV-positive Children in Southern China.
Xue X; Zou J; Fang W; Liu X; Chen M; Arastehfar A; Ilkit M; Zheng Y; Qin J; Peng Z; Hu D; Liao W; Pan W
Mycopathologia; 2022 Jun; 187(2-3):169-180. PubMed ID: 35157189
[TBL] [Abstract][Full Text] [Related]
8. Disseminated
Xu L; Chen X; Yang X; Jiang H; Wang J; Chen S; Xu J
Front Cell Infect Microbiol; 2023; 13():1115268. PubMed ID: 36816584
[TBL] [Abstract][Full Text] [Related]
9. Unusual disseminated Talaromyces marneffei infection mimicking lymphoma in a non-immunosuppressed patient in East China: a case report and review of the literature.
Chen D; Chang C; Chen M; Zhang Y; Zhao X; Zhang T; Wang Z; Yan J; Zhu H; Zheng L; Zhao K
BMC Infect Dis; 2020 Oct; 20(1):800. PubMed ID: 33115429
[TBL] [Abstract][Full Text] [Related]
10. Pneumonia caused by Talaromyces marneffei in an epidermal growth factor receptor (EGFR) mutation-positive advanced lung adenocarcinoma patient: a case report.
Liu W; Xu J; Lin B; Zhang Y; Xie F; Zhou C; Lai G; Zhang L; Yu Z
Ann Palliat Med; 2021 Jan; 10(1):759-766. PubMed ID: 33440949
[TBL] [Abstract][Full Text] [Related]
11. Dermatoscopy for the rapid diagnosis of Talaromyces marneffei infection: a case report.
Xian J; Huang X; Li Q; Peng X; Peng X
BMC Infect Dis; 2019 Aug; 19(1):707. PubMed ID: 31399065
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China.
Lei HL; Li LH; Chen WS; Song WN; He Y; Hu FY; Chen XJ; Cai WP; Tang XP
Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1099-1102. PubMed ID: 29536323
[TBL] [Abstract][Full Text] [Related]
13. Effect of combination antiretroviral therapy on the clinical manifestations, radiological characteristics, and disease severity of HIV-associated
Shi X; Yan Q; Zhan Y; Shi C; Song F; Wang L; Qi T; Lu H; Shan F; Shi Y
Int J STD AIDS; 2020 Jul; 31(8):747-752. PubMed ID: 32631212
[TBL] [Abstract][Full Text] [Related]
14. Accurate diagnosis of bronchopulmonary
Chen G; Ma N; Zhu D; Zhou H; Liang Q; Meng J; Shen Y; Liu H; Liu L; He Z; Qin Z
Front Cell Infect Microbiol; 2023; 13():1186335. PubMed ID: 37860065
[TBL] [Abstract][Full Text] [Related]
15. Case Report:
Ba H; Peng H; Cheng L; Lin Y; Li X; He X; Li S; Wang H; Qin Y
Front Immunol; 2021; 12():685546. PubMed ID: 34234782
[No Abstract] [Full Text] [Related]
16. Clinical Characteristics of Transplant Recipients Infected with Talaromyces Marneffei: 2 Case Reports and a Literature Review.
Xing S; Zhang H; Qiu Y; Pan M; Zeng W; Zhang J
Infect Drug Resist; 2022; 15():2879-2890. PubMed ID: 35686193
[TBL] [Abstract][Full Text] [Related]
17. Talaromyces marneffei infection in a lung cancer patient: a rare case report.
Lin F; Qiu Y; Zeng W; Liang Y; Zhang J
BMC Infect Dis; 2019 Apr; 19(1):336. PubMed ID: 31014277
[TBL] [Abstract][Full Text] [Related]
18. Successful voriconazole treatment of Talaromyces marneffei infection in an HIV-negative patient with osteolytic lesions.
Ge Y; Xu Z; Hu Y; Huang M
J Infect Chemother; 2019 Mar; 25(3):204-207. PubMed ID: 30195473
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of Talaromyces marneffei infection in a kidney transplant recipient with voriconazole followed by itraconazole for the first time.
Li Y; Tang M; Sun S; Hu Q; Deng S
J Mycol Med; 2022 Mar; 32(1):101214. PubMed ID: 34763148
[TBL] [Abstract][Full Text] [Related]
20. Voriconazole Versus Amphotericin B as Induction Therapy for Talaromycosis in HIV/AIDS Patients: A Retrospective Study.
Huang W; Li T; Zhou C; Wei F; Cao C; Jiang J
Mycopathologia; 2021 May; 186(2):269-276. PubMed ID: 33616828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
